Atlas Trials

Study on the Safety and Effectiveness of Risperidone Treatment of Acute Psychotic Patients

Clinical trial NCT00515489 · TERMINATED

Trial details

NCT number
NCT00515489
Sponsor
Janssen-Cilag, S.A.
Status
TERMINATED
Study type
OBSERVATIONAL
SchizophreniaSchizoaffective DisorderSchizophreniform Disorders
Start date
2001-11-01
Enrollment
1882

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.